These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 7468316)
1. Blood pressure control in a middle-aged male population. A 6-9 year follow-up with special reference to the problem of non-responders. Aberg H; Hadstrand H; Lithell H Acta Med Scand; 1980; 208(6):467-71. PubMed ID: 7468316 [TBL] [Abstract][Full Text] [Related]
2. [Quality of blood pressure control in general practice and in the HOT study. French Research Group HOT (Hypertension Optimal Treatment)]. Raveau-Landon C Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1179-81. PubMed ID: 8572869 [TBL] [Abstract][Full Text] [Related]
3. Control of hypertension in Italy: results of the "Study on Antihypertensive Treatment in General Practice (STAP)". Physicians Taking Part in STAP. Avanzini F; Alli C; Colombo P; Corsetti A; Colombo F; Tognoni G G Ital Cardiol; 1998 Jul; 28(7):760-6. PubMed ID: 9773300 [TBL] [Abstract][Full Text] [Related]
4. [Determination of prevalence and control level of hypertension in the community: Hypertension Management Audit Project--Vicenza]. Vincenzi M; La Vecchia L G Ital Cardiol; 1992 Apr; 22(4):427-40. PubMed ID: 1426784 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [TBL] [Abstract][Full Text] [Related]
7. Blood pressure control among hypertensives managed in a specialised health care setting in Nigeria. Isezuo AS; Njoku CH Afr J Med Med Sci; 2003 Mar; 32(1):65-70. PubMed ID: 15030069 [TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
9. [Influence of some parameters on the blood pressure reduction under treatment: experience from the Hypertension Optimal Treatment Study]. Mallion JM; Baguet JP; Siché JP; Benkritly A Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1049-53. PubMed ID: 9749163 [TBL] [Abstract][Full Text] [Related]
10. The primary preventive study in Uppsala. Fatal and non-fatal myocardial infarction during a 10-year follow-up of a middle-aged male population with treatment of high-risk individuals. Lithell H; Aberg H; Selinus I; Hedstrand H Acta Med Scand; 1984; 215(5):403-9. PubMed ID: 6741605 [TBL] [Abstract][Full Text] [Related]
11. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study. Siewert-Delle A Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group. Fogari R; Zoppi A; Lusardi P; Mugellini A Blood Press Suppl; 1996; 5():24-8. PubMed ID: 8973789 [TBL] [Abstract][Full Text] [Related]
13. Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study. Tervahauta M; Pekkanen J; Enlund H; Nissinen A J Hypertens; 1994 Oct; 12(10):1183-9. PubMed ID: 7836735 [TBL] [Abstract][Full Text] [Related]
14. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden. Hedblad B; Nerbrand C; Ekesbo R; Johansson L; Midlöv P; Brunkstedt I; Svensson P; Gyllerup S; Sträng B; Persson R; Janzon L Scand J Prim Health Care; 2006 Dec; 24(4):224-30. PubMed ID: 17118862 [TBL] [Abstract][Full Text] [Related]
15. The Hypertension Optimal Treatment study and the importance of lowering blood pressure. Hansson L J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838 [TBL] [Abstract][Full Text] [Related]
16. [Blood pressure control after a one year follow-up in high risk subject screened in occupational medicine]. Cambou JP; Cothereau C; Chatellier G; Saliou P; Thomas D; Capron L Arch Mal Coeur Vaiss; 2005; 98(7-8):789-93. PubMed ID: 16220749 [TBL] [Abstract][Full Text] [Related]
17. Normotensive middle-aged men after 5-10 years: normal blood pressure or hypertension? Seccareccia F; Lanti M; Puddu PE; Menotti A J Hypertens Suppl; 1988 Dec; 6(4):S602-4. PubMed ID: 3241261 [TBL] [Abstract][Full Text] [Related]
18. [Prevalence, treatment and control of hypertension in family practice patients in France during 1994]. Poggi L; Chamontin B; Lang T; Menard J; Chevalier H; Gallois H; Cremier O Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1075-80. PubMed ID: 8949382 [TBL] [Abstract][Full Text] [Related]
19. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension. Manyemba J Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111 [TBL] [Abstract][Full Text] [Related]
20. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study. Ishikawa J; Kario K; Eguchi K; Morinari M; Hoshide S; Ishikawa S; Shimada K; Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]